# Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

> **NCT03859388** · — · ACTIVE_NOT_RECRUITING · sponsor: **Cedars-Sinai Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Rejection Chronic Renal
- Kidney Transplant Rejection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03859388
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859388, "Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03859388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*